Our analysts have extensive expertise across the entire healthcare and life science value chain, and provide fact-based research and analysis on best practices and the use of information technology to assist healthcare and life science organizations to improving performance and maximize technology investments.

Decentralized clinical trials are reshaping the life science industry. As organizations are rapidly attempting to transition from a 'pilotitis' mode to an enterprisewide implementation strategy, they need to take cognizance of the importance of defining key performance indicators, which will serve as measures of success through their DCT journey. The life science industry needs to develop a 'DCT Organizational Maturity Score' for DCT implementation, akin to a capability maturity model (CMM), which will help organizations to benchmark their performance, against themselves and against the industry.

Doc# US50241323 Nimita Limaye - Research Vice President